Cargando…

Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma

Detalles Bibliográficos
Autores principales:	Li, Yi, Yang, Bin, Ma, Yanchun, Peng, Xiaojun, Wang, Zhiyu, Sheng, Bin, Wei, Zichao, Cui, Yongping, Liu, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585941/ https://www.ncbi.nlm.nih.gov/pubmed/34764241 http://dx.doi.org/10.1038/s41392-021-00682-5

Ejemplares similares

Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma
por: Yuan, Qiang, et al.
Publicado: (2019)

An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma
por: Gao, Yingzhen, et al.
Publicado: (2022)

A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma
por: Yan, Ting, et al.
Publicado: (2022)

The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma
por: Zuo, Jing, et al.
Publicado: (2022)

Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
por: Yan, Ting, et al.
Publicado: (2019)

NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma
por: Wang, Shiwen, et al.
Publicado: (2020)

Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
por: Yan, Ting, et al.
Publicado: (2020)

Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
por: Liu, Wei, et al.
Publicado: (2022)

DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilities
por: Zhao, Ning, et al.
Publicado: (2023)

Identification of a Metastasis-Related Protein IFI16 in Esophageal Cancer using a Proteomic Approach
por: Wang, Zhiyu, et al.
Publicado: (2022)

The macro-evolutionary events in esophageal squamous cell carcinoma
por: Yang, Bin, et al.
Publicado: (2017)

Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma
por: Chu, Jiahui, et al.
Publicado: (2020)

EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019)

Expression of SLP-2 Was Associated with Invasion of Esophageal Squamous Cell Carcinoma
por: Cao, Wenfeng, et al.
Publicado: (2013)

Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma
por: Zou, Binbin, et al.
Publicado: (2022)

Single‐cell sequencing of multi‐region resolves geospatial architecture and therapeutic target of endothelial cells in esophageal squamous cell carcinoma
por: Dai, Jiacheng, et al.
Publicado: (2023)

Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma
por: Cheng, Caixia, et al.
Publicado: (2016)

Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma
por: Yan, Wusheng, et al.
Publicado: (2012)

Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
por: Cheng, Caixia, et al.
Publicado: (2016)

Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
por: Cui, Yongping, et al.
Publicado: (2020)

An esophageal squamous cell carcinoma classification system that reveals potential targets for therapy
por: Xiong, Teng, et al.
Publicado: (2017)

Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Ling, et al.
Publicado: (2015)

Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Ling, et al.
Publicado: (2020)

Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Ling, et al.
Publicado: (2020)

Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma
por: Shao, Ying, et al.
Publicado: (2015)

A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma
por: Lv, Jiali, et al.
Publicado: (2021)

FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma
por: Hu, Xiaoling, et al.
Publicado: (2018)

ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2022)

Targeting Aberrant Histone Posttranscription Modification Machinery in Esophageal Squamous Cell Carcinoma: Current Findings and Challenges
por: Ma, Gang, et al.
Publicado: (2022)

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma
por: Cui, Xiao-bin, et al.
Publicado: (2016)

Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of esophageal squamous cell carcinoma
por: Liu, Mingdi, et al.
Publicado: (2021)

Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
por: Xian, Jingrong, et al.
Publicado: (2022)

Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma From Chinese Patients
por: Pan, Lulu, et al.
Publicado: (2020)

Proteome and phosphoproteome signatures of recurrence for HPV(+) head and neck squamous cell carcinoma
por: Kaneko, Tomonori, et al.
Publicado: (2022)

Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
por: Cui, Heyang, et al.
Publicado: (2021)

JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC
por: Li, Shu-Man, et al.
Publicado: (2020)

Role of Epidermal Growth Factor Receptor-Specific CAR-T Cells in the Suppression of Esophageal Squamous Cell Carcinoma
por: Cheng, Chen, et al.
Publicado: (2022)

TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2
por: Zhang, Ling, et al.
Publicado: (2020)

c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target
por: Ozawa, Yohei, et al.
Publicado: (2015)

Constitutive activated STAT3 is an essential regulator and therapeutic target in esophageal squamous cell carcinoma
por: Tian, Fang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sq19sgnt5a9jgq14rqahoh8p3m